Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genetic modifiers of GFAP expression in mouse models of Alexander disease

ABSTRACT: Gene expression analysis was performed in mouse models with Alexander disease associated GFAP mutations

ORGANISM(S): Mus musculus

PROVIDER: GSE197044 | GEO | 2023/01/17

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Microglia sense astrocyte dysfunction and prevent disease progression in an Alexander disease model

Project description:Alexander disease is a neurodegenerative diseases caused by mutations of GFAP, an astrocyte-specific gene. We used single cell RNA sequencing (scRNA-seq) to analyze the diversity of astrocytes.

2023-11-12 | GSE242666 | GEO

GFAP transgenic mice expression analysis

Project description:Olfactory bulb transcript levels for GFAP transgenic mice compared to wildtype at 3wks and 4mos Keywords = GFAP Keywords = Rosenthal fibers Keywords = Alexander disease Keywords: other

2005-07-20 | GSE977 | GEO

Aberrant neurodevelopment in human iPS cell-derived neural organoid model of Alexander disease

Project description:3D-cultured unguided neural and cortical organoids derived from human iPS cells carrying a GFAP (R239C) mutation - an identified cause of Alexander disease (AxD) - and their isogenic controls were analyzed with scRNA-seq to investigate the effect of the GFAP mutation on brain development, cell type composition, and gene expression. Results of this analysis showed impaired astro- and neurogenesis in both types of organoids (unguided and cortical), including a lack of cells acquiring the astrocyte fate, and an increased abundance of cells differentiating into lineages other than neuroectodermal. The results also suggested dysregulation of extracellular matrix, membrane, and cytoskeleton components, which might have also affected their differentiation trajectories.

2024-04-07 | GSE261157 | GEO

Region specific astrocyte response to mutant GFAP in Alexander disease model mice during postnatal development.

Project description:Gene expression analysis was performed in Gfap+/+, Gfap+/R236H, and mGFAPTg170-2 transgenic mice, using the Aldh1l1-eGFP-L10a transgenic line (JD130) to isolate translating ribosomes and purify astrocyte specific transcripts for RNAseq.

2023-01-17 | GSE198817 | GEO

Composition of Rosenthal fibers in Alexander disease patients and mouse models

Project description:Alexander disease (AxD) is a fatal neurodegenerative disorder characterized by the presence in astrocytes of protein aggregates called Rosenthal fibers (RFs). In this work, we used a new biochemical fractionation method to enrich for RFs followed by analysis of this fraction using quantitative iTRAQ mass spectrometry. This work identified 77 proteins not previously associated with RFs. Multiple proteins selected for follow-up were confirmed by immunobloting to be enriched in the RF fraction of both the AxD mouse models and human AxD patients including receptor for activated protein C kinase 1 (RACK1), G1/S-specific cyclin D2, and ATP-dependent RNA helicase DDX3X.

2016-05-23 | PXD002448 | Pride

Aberrant neurodevelopment in human iPS cell-derived astrocyte-neuron co-culture model of Alexander disease

Project description:Co-cultures of neurons and astrocytes derived from human iPS cells carrying a GFAP (R239C) mutation - an identified cause of Alexander disease (AxD) - were analyzed with single-cell RNA sequencing to assess cell population composition, differential gene expression, and cell-cell interaction differences in AxD co-cultures compared to controls. Oxygen-glucose deprivation (OGD) challenge was applied to identify differences in stress response. Our results suggested differentiation impairment especially in AxD astrocytes, represented by an enriched population of less differentiated cells and downregulation of mature astrocyte genes in AxD astrocytes-containing co-cultures. Furthermore, AxD co-cultures showed increased stress response represented by upregulation of metallothioneins and increased susceptibility to the OGD challenge.

2024-04-07 | GSE261110 | GEO

GFAP expression as an indicator of disease severity in mouse models of Alexander disease.

Project description: Not available

| S-EPMC3604736 | biostudies-literature

Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease.

Project description: Not available

| S-EPMC2655774 | biostudies-literature

GFAP and its role in Alexander disease.

Project description: Not available

| S-EPMC2702672 | biostudies-literature

Gene expression changes associated with Alexander disease (AxD)

Project description:Gene expression changes associated with Alexander disease (AxD)